Therapy News and Research

RSS

TSRI-led team devises selection-based, protein-engineering method to work on obesity therapy

Some proteins exist so fleetingly in the bloodstream that they can’t be given effectively as therapies. However, building them into larger proteins, such as antibodies, can make them persist long enough to be useful. Now a team led by scientists at The Scripps Research Institute has devised an improved method for accomplishing this protein-engineering feat.

14 Aug 2015

Researchers use advanced photodynamic therapy to combat ovarian cancer in laboratory animals

Researchers at Oregon State University have made a significant advance in the use of photodynamic therapy to combat ovarian cancer in laboratory animals, using a combination of techniques that achieved complete cancer cell elimination with no regrowth of tumors.

14 Aug 2015

Researchers develop new way to personalize treatments for aggressive bladder cancer

Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer.

14 Aug 2015

Rush researchers explore new stem cell therapy to treat spinal cord injuries

Researchers at Rush University Medical Center are exploring a new therapy using stem cells to treat spinal cord injuries within the first 14 to 30 days of injury. Rush is only the second center in the country currently studying this new approach.

14 Aug 2015

Merck, MD Anderson form strategic clinical research collaboration to evaluate anti-PD-1 therapy

Merck and The University of Texas MD Anderson Cancer Center announced a strategic clinical research collaboration to evaluate Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel anti-tumor medicines.

14 Aug 2015

Rhythm Metabolic completes $40 million Series A financing

Rhythm announced today the completion of a $40 million Series A financing for its subsidiary, Rhythm Metabolic, Inc., which is developing setmelanotide (RM-493), a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies in the MC4 pathway.

13 Aug 2015

Health Gorilla announces launch of expanded physician portal

Health Gorilla today announced the launch of its expanded physician portal, part of a new clinical network the company will unveil next month to connect doctors, vendors, and patients within a single, secure platform.

13 Aug 2015

ESC Congress to highlight results from global trials in six press conferences

Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.

13 Aug 2015

New study explains why statins are more beneficial than others in some cases

Statins' success in reducing atherosclerosis-related events has elevated the medications to wonder-drug status, with some researchers advocating for their wider use as a preemptive therapy for cardiovascular disease.

13 Aug 2015

FGF protein may play key role in breast and prostate cancer, shows research

Simply put, cancer is caused by mutations to genes within a cell that lead to abnormal cell growth. Finding out what causes that genetic mutation has been the holy grail of medical science for decades.

13 Aug 2015

Newly developed big data technique may have significant impact on health care

Rice University scientists have developed a big data technique that could have a significant impact on health care. The Rice lab of bioengineer Amina Qutub designed an algorithm called "progeny clustering" that is being used in a hospital study to identify which treatments should be given to children with leukemia.

13 Aug 2015

First clinical trial to test use of retinal progenitor cells for treating retinitis pigmentosa begins

Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa, reported project director Dr. Henry Klassen of UCI's Gavin Herbert Eye Institute and Sue & Bill Gross Stem Cell Research Center. The product of stem cell research at UCI, these retinal progenitors are similar to stem cells in terms of potential regenerative properties, but they're specific to the retina.

13 Aug 2015

Dynatronics granted U.S. patent for ThermoStim Probe

Dynatronics Corporation today announced its patent for "Systems and Methods for Providing a Thermo-electro-stimulation Probe Device" (US Patent No. 9,084,665) has been granted by the U.S. Patent and Trademark Office. This technology is incorporated in the company's ThermoStim Probe used in the delivery of therapeutic treatments.

12 Aug 2015

$AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion$

AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion

AbbVie, a global biopharmaceutical company, today announced that a Phase 2 trial of its investigational medicine venetoclax met its primary endpoint of achieving overall response rates in patients with relapsed/refractory or previously untreated chronic lymphocytic leukemia (CLL) with 17p deletion, according to an independent review analysis.

12 Aug 2015

Postmenopausal women more likely to use vaginal estrogen to achieve significantly higher sexual quality of life

Local vaginal estrogen (VE) appears to have escaped the shroud of doubt cast upon hormone therapy as a result of the Women's Health Initiative Study by providing numerous medical benefits without systemic effects. That's according to a new study reported online today in Menopause, the journal of The North American Menopause Society.

12 Aug 2015

NxStage System One now used in eight of Top 10 Nephrology Hospitals in the U.S.

NxStage Medical, Inc., a leading manufacturer of dialysis products, today announced that the NxStage System One is now used in eight of the Top 10 Nephrology Hospitals in the United States as ranked according to U.S. News & World Report.

12 Aug 2015

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced that it has entered into a license agreement with Advanced Dosage Forms, Inc. to expand Imprimis' proprietary ophthalmic injectable and combination topical compounded formulations into Canada. Under the agreement, the licensee has the rights to formulate, market and sell these formulations across Canada.

12 Aug 2015

Concord Medical closes acquisition of additional ownership interest in MD Anderson Proton Therapy Center

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it has closed the acquisition of additional ownership interest of The University of Texas MD Anderson Cancer Center Proton Therapy Center ("MD Anderson Proton Therapy Center").

12 Aug 2015

Researchers elucidate mechanism that induces skeletal muscle atrophy in patients with congestive heart failure

It is a paradox: Patients with advanced congestive heart failure lose skeletal muscle mass, but their heart muscles become enlarged to provide the body with an adequate supply of blood and thus with oxygen. It has long been known that the protein angiotensin II plays a villainous role in this process, but the exact mechanism has remained unclear.

12 Aug 2015

Johns Hopkins and Mayo Clinic cardiologists suggest upgrades to controversial heart disease prevention guidelines

Acknowledging key strengths and "lessons learned," preventive cardiologists from Johns Hopkins and Mayo Clinic have developed a short list of suggested upgrades to the controversial heart disease prevention guidelines issued jointly in 2013 by the American Heart Association and the American College of Cardiology.

12 Aug 2015

Therapy News and Research

TSRI-led team devises selection-based, protein-engineering method to work on obesity therapy

Researchers use advanced photodynamic therapy to combat ovarian cancer in laboratory animals

Researchers develop new way to personalize treatments for aggressive bladder cancer

Rush researchers explore new stem cell therapy to treat spinal cord injuries

Merck, MD Anderson form strategic clinical research collaboration to evaluate anti-PD-1 therapy

Rhythm Metabolic completes $40 million Series A financing

Health Gorilla announces launch of expanded physician portal

ESC Congress to highlight results from global trials in six press conferences

New study explains why statins are more beneficial than others in some cases

FGF protein may play key role in breast and prostate cancer, shows research

Newly developed big data technique may have significant impact on health care

First clinical trial to test use of retinal progenitor cells for treating retinitis pigmentosa begins

Dynatronics granted U.S. patent for ThermoStim Probe

AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion

Postmenopausal women more likely to use vaginal estrogen to achieve significantly higher sexual quality of life

NxStage System One now used in eight of Top 10 Nephrology Hospitals in the U.S.

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Concord Medical closes acquisition of additional ownership interest in MD Anderson Proton Therapy Center

Researchers elucidate mechanism that induces skeletal muscle atrophy in patients with congestive heart failure

Johns Hopkins and Mayo Clinic cardiologists suggest upgrades to controversial heart disease prevention guidelines

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News